Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands Shadi Dalili, Craig D. Simpson, et al. Mol Cancer Ther 2010;9:246-256
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.